Malaria in pregnancy
|
Malaria in pregnancy increases the risk of maternal anaemia, stillbirth, spontaneous abortion, low birth weight and neonatal death. WHO recommends a package of interventions for the prevention and control of malaria during pregnancy:
|
|
Technical Expert Group meeting on intermittent preventive treatment in pregnancy (IPTp)
WHO HEADQUARTERS, GENEVA, 11–13 JULY 2007
The Global Malaria Programme/WHO held a technical consultation in Geneva
on 11.13 July 2007 to appraise available evidence on IPTp against the background of
the various limitations and changing environment described above, with the primary
objective of:
1. Developing a framework, plan, and methodology to monitor and evaluate the
efficacy and effectiveness of on going SP-IPTp:
2. Reviewing the evidence on efficacy and safety of SP-IPTp, with a view to
updating WHO guidelines on IPTp.
3. Identifying gaps in knowledge and defining a research agenda for IPTp for
guiding future policy direction.
The panel comprised of 15 independent Experts. The Consultation was attended by
observers from UNICEF, the Bill and Melinda Gates foundation, and the IPTi
Consortium (Appendix 1, List of participants).
Assessment of the Safety of Artemisinin Compounds in Pregnancy
WHO/CDS/MAL/20903.1094
WHO/GMP/TDR/Artemisinin/07.1
In 2006 WHO/GMP and TDR convened joint informal consultations to review existing data and policies on the use of artemisinin compounds in pregnancy. At the first consultation experts in reproductive and developmental toxicity discussed new published and unpublished data on the toxicity of artemisinins in rodents and primates. In addition, studies using whole embryo culture as well as isolated cells were reviewed. A second consultation reviewed the recent safety and efficacy data on the use of artemisinin compounds in early pregnancy and outlined new approaches needed to obtain more safety information.
A Strategic Framework for Malaria Prevention and Control during Pregnancy in the African Region
AFR/MAL/04/01
Guidance for policy-makers and national programmes on the prevention and control of malaria in pregnant women.
Recommendations on the use of Sulfadoxine-Pyrimethamine (SP) for Intermittent Preventive Treatment during Pregnancy (IPT) in areas of moderate to high resistance to SP in the African Region
Malaria in Pregnancy: Guidelines for Measuring Key Monitoring and Evaluation
Indicators
WHO 2007
ISBN:978 92 4 159 563 6
Provides guidance for countries on the monitoring and evaluation of malaria in pregnancy programmes.
[Version française
]
Prevention of malaria in pregnancy
Recommendations
WHO Expert Committee recommendation
WHO Technical Report Series — 892
WHO Expert Commitee on Malaria recommends Intermittent Preventive Treatment of malaria in pregnancy.
P Marchesini, J Crawley Reducing the burden of malaria in pregnancy
Mera, January 2004
Short review that describes the tools that are currently available for the prevention and control of malaria in pregnancy.
M Parise, L Lewi, J Ayisi, B Nahlen, L Slutsker, R Muga. A Rapid Assessment Approach for Public Health Decision-making Related to the Prevention of Malaria during Pregnancy
Bulletin of the World Health Organization 2003, 81 (5)
The article describes a rapid field assessment methodology for addressing the burden of malaria during pregnancy.
RELATED LINKS
